YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Byetta
Byetta Patients Report Kidney Problems, Label Revised
Nov 3, 2009 | Parker Waichman Alonso LLP
The labeling for Byetta, a drug used to treat type 2 diabetes, has been revised to include new safety information about possible kidney function...
Another Byetta Delay
Dec 9, 2008 | Parker Waichman Alonso LLP
Federal regulators are extending a review of the diabetes drug Byetta into next year, Forbes.com is reporting. The Food & Drug...
Flagging Byetta Sales Force Job Cuts at Amylin
Nov 12, 2008 | Parker Waichman Alonso LLP
Safety concerns surrounding the diabetes drug Byetta have slowed its sales, forcing Amylin Pharmaceuticals to cut a quarter of its work force....
Long-Acting Byetta Faces Approval Obstacles
Nov 5, 2008 | Parker Waichman Alonso LLP
A new version of Byetta, a diabetes drug made by Amylin Pharmaceuticals Inc. and Eli Lilly & Co., isn't going to be approved by the Food &...
New Diabetes Drugs More Expensive, But Not Always Better
Oct 28, 2008 | Parker Waichman Alonso LLP
A new report has found that the cost for treating diabetes has skyrocketed, despite inconclusive evidence that newer, more expensive treatments...
Amylin Releases Questionable Byetta Study in Attempt to Take Focus From Pancreatitis Risk
Sep 10, 2008 | Parker Waichman Alonso LLP
Byetta maker, Amylin Pharmaceuticals, is trying to save the diabetes drug's reputation by touting a new study that shows it to be more effective than...
Byetta Linked to More Deaths
Aug 27, 2008 | Parker Waichman Alonso LLP
Byetta has been implicated in six deaths, four more than federal regulators reported last week. The additional deaths were revealed late...
Byetta Linked to Fatal Cases of Necrotizing or Hemorrhagic Pancreatitis
Aug 18, 2008 | Parker Waichman Alonso LLP
Byetta, a drug used to treat type 2 diabetes, has been linked to hemorrhagic or necrotizing pancreatitis, prompting the Food & Drug...
Byetta to Get New Side Effects Warnings Following Pancreatitis Reports
Oct 17, 2007 | Parker Waichman Alonso
The makers of Byetta have agreed to include new side effects warnings on its label following reports that link the diabetes drug to the development...
Page 1/1
Defective Drugs
